Institute of Clinical and Molecular Virology

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models (2023) Timotius IK, Roelofs RF, Richmond-Hacham B, Noldus LP, von Hörsten S, Bikovski L Journal article, Review article Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model (2023) Schmidt A, Paudyal B, Villanueva-Hernández S, Mcnee A, Vatzia E, Carr BV, Schmidt S, et al. Journal article Precise excision of HTLV-1 provirus with a designer-recombinase (2023) Rojo-Romanos T, Karpinski J, Millen S, Beschorner N, Simon F, Paszkowski-Rogacz M, Lansing F, et al. Journal article Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine (2023) Schmidt K, Harrer E, Schönau V, Simon D, Kleyer A, Steininger P, Korn K, et al. Journal article Behavioural effects of APH199, a selective dopamine D4 receptor agonist, in animal models (2023) Chestnykh D, Graßl F, Pfeifer C, Dülk J, Ebner C, Walters M, von Hörsten S, et al. Journal article Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation (2023) Chen DY, Chin CV, Kenney D, Tavares AH, Khan N, Conway HL, Liu GQ, et al. Journal article The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types (2023) Hahn F, Wangen C, Häge S, Herrmann L, Herrmann A, Tsogoeva S, Marschall M Journal article A Novel Window into Angiogenesis — Intravital Microscopy in the AV-Loop-Model (2023) Vaghela R, Arkudas A, Gage D, Körner C, von Hörsten S, Salehi S, Horch RE, Hessenauer M Journal article Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination (2022) Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht KM, Wytopil M, et al. Journal article In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant (2022) Heinen N, Marheinecke CS, Bessen C, Blazquez-Navarro A, Roch T, Stervbo U, Anft M, et al. Journal article